Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 placebo-controlled trial of EDS-EP in ataxia-telangiectasia
MOH_2021-08-31_010230Phase 3Completed
- Sponsor
- EryDel S.p.A.
- Start
- Sep 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexamethasone sodium phosphate in ataxia-telangiectasia (AT) (3 arms), sponsored by EryDel S.p.A. Started Sep 2016; status: completed.
02
Drugs
dexamethasone sodium phosphate
03
Conditions
ataxia-telangiectasia (AT)
Beyond the preview
Go deeper on MOH_2021-08-31_010230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2021-08-31_010230.